Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-12

Clinical Trial Update: Chromium's Effect on Insulin Resistance in Obesity [NA]

View source ↗

Summary

The clinical trial evaluating chromium's effect on insulin resistance in obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chromium Picolinate (chromium picolinate)

Snippet

Sponsor: Stony Brook University | Conditions: Insulin Resistance, Obesity | NA | Status: COMPLETED